R&D
Rare disease at an inflection point: Why the next wave will ...
As rare disease becomes more competitive, information parity is disappearing.
Digital
Trends & Insights, January 2026: A pharmaphorum industry rep...
Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
R&D
Net Treatment Benefit in rare disease trials: Aligning trial...
Net Treatment Benefit provides a formal framework to integrate multiple prioritised outcomes into a single measure of overall treatment effect.
R&D
How innovative trial approaches are advancing rare disease r...
Innovative trial designs that harness data augmentation, RWD, and the power of AI are enabling a new era of rare disease research.
Market Access
What rare disease commercialisation in Europe teaches us - a...
Rare disease launches are the ultimate stress test for European commercialisation.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
